How to effectively diagnose a tumor?

 

 

PATENT:

2803734

INVENTION:

PSMA-targeting compound and its complex with radionuclides for theranostics of PSMA-expressing tumors

INVENTOR(S):

A. M. Orlova, K. Seitova, V. V. Bodenko, F. Lundmark, A. Abuzajed, U. Rosenstrem

PATENTEE:

Tomsk Polytechnic University

PURPOSE:

For cancer diagnosis and treatment

INNOVATION:

Diagnosis and treatment of cancer is a serious public health problem: it is important to detect and recognize cancer in time. Well-known medicine for diagnosis and treatment contains radioactive elements that allow to see the tumor, but also negatively affect healthy cells, and tissues receive some dose of radiation.

The synthesized new chemical compound in complex with the radioactive element lutetium can selectively bind to cancer cells without accumulating in healthy tissues. The resulting medicine has low toxicity and can be used at a lower dose for diagnosis and treatment of tumors.

SCOPE
OF APPLICATION:

organic and medicinal chemistry, oncology. The proposed solution is especially relevant in the terms of import substitution.

For more information about this patent, please follow the link (in Russian).

 

Print

Share:

Last page update:

All updates
next news
Rospatent Presents Reports of 3D and Blockchain Task Forces at the Committee on WIPO Standards
go to news list

Font size

Kourcing:

Яндекс.Метрика